{"id":8855,"date":"2015-03-14T11:20:06","date_gmt":"2015-03-14T10:20:06","guid":{"rendered":"http:\/\/www.fedaiisf.it\/?p=8855"},"modified":"2015-05-03T18:26:35","modified_gmt":"2015-05-03T16:26:35","slug":"notiziario-fedaiisf-46","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/notiziario-fedaiisf-46\/","title":{"rendered":"News 46"},"content":{"rendered":"<div style=\"text-align: center;\"><b>\u00a0<\/b><\/div>\n<div style=\"text-align: center;\">\n<h4 style=\"text-align: center;\">ON THIS ISSUE:<\/h4>\n<p style=\"text-align: center;\"><strong>\u2013 EU: R&amp;D Pharma is not up to investment;<\/strong><\/p>\n<p style=\"text-align: center;\"><strong>\u2013 in 2015 at least 11 new blockbusters: will they be future successes?;<\/strong><\/p>\n<p style=\"text-align: center;\"><strong>\u2013 Big Pharma, an 870 million euro deal;<\/strong><\/p>\n<p style=\"text-align: center;\"><strong>\u2013 no computer and tablet can replace an ISF;<\/strong><\/p>\n<p style=\"text-align: center;\"><strong>\u2013 Renzi government enemy of drugs.<\/strong><\/p>\n<h3><strong><span style=\"color: #ff0000;\">Click to read this issue <\/span><span style=\"color: #0000ff;\"><a style=\"color: #0000ff;\" href=\"http:\/\/www.fedaiisf.it\/en\/notiziario-46-2\/\"><span style=\"text-decoration: underline;\">here<\/span><br \/>\n<\/a><\/span><\/strong><\/h3>\n<h3><\/h3>\n<h4><strong><span style=\"color: #0000ff;\">Newsletter 46 \u2013 FEDAIISF newsletter Year 7 n.46 -2015<\/span><\/strong><\/h4>\n<\/div>\n<div style=\"text-align: center;\"><a href=\"http:\/\/www.fedaiisf.it\/wp-content\/uploads\/2015\/03\/fedaiisf-46.png\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone  wp-image-8856\" src=\"http:\/\/www.fedaiisf.it\/wp-content\/uploads\/2015\/03\/fedaiisf-46-300x168.png\" alt=\"fedaiisf 46\" width=\"616\" height=\"345\" \/><\/a><\/div>","protected":false},"excerpt":{"rendered":"<p>\u00a0 SU QUESTO NUMERO: &#8211; UE: R&amp;D Pharma non \u00e9 all\u2019altezza degli investimenti; &#8211; nel 2015 almeno 11 nuovo blockbuster: saranno futuri successi?; &#8211; Big Pharma, un affare da 870 milioni di euro; &#8211; nessun computer e tablet potranno sostituire un ISF; &#8211; Governo Renzi nemico dei farmaci. Per leggere questo numero clicca qui Notiziario &hellip;<\/p>","protected":false},"author":1,"featured_media":8856,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[14],"tags":[81],"class_list":["post-8855","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-fedaiisf","tag-notiziario-fedaiisf"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/8855","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=8855"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/8855\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/8856"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=8855"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=8855"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=8855"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}